(2001) tested BPC-157 on rats consuming alcohol daily for three months at 7.28 g/kg per day
Common (5-15% of users): Mild injection site reactions, minor digestive changes Uncommon (1-5%): Sleep changes, temporary fatigue, mild headache Rare (under 1%): Dizziness, flushing, mood changes Very Rare: Serious adverse effects rarely reported in community use Theoretical Concerns BPC-157s ability to stimulate angiogenesis (blood vessel formation) raises theoretical questions about its use in individuals with active cancer or high cancer risk
The recommended daily dosage should not be exceeded
Their customer service is top-notchsuper reliable and truly committed to making sure customers are happy
It is not FDA-approved, is research-use-only, and is not for human consumption
Metabolic shifts, such as in glucose handling, must be monitored in at-risk men